In vivo enhancement of tumour-specific T cells via peptide–MHC-pseudotyped retroviral gene delivery
Nature Reviews Immunology, Published online: 08 January 2025; doi:10.1038/s41577-024-01128-zA preprint by Xu et al. shows that MHC-pseudotyped retroviruses can reprogramme, activate and expand tumour-specific T cell populations in vivo.